783 related articles for article (PubMed ID: 25194335)
21. The diagnostic significance of serum IgG4 levels in patients with autoimmune pancreatitis: a UK study.
Sadler R; Chapman RW; Simpson D; Soonawalla ZF; Waldegrave EL; Burden JM; Misbah SA; Ferry BL
Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):139-45. PubMed ID: 21287719
[TBL] [Abstract][Full Text] [Related]
22. Serum immunoglobulin G4 associated with number and distribution of extrapancreatic lesions in type 1 autoimmune pancreatitis patients.
Kaji R; Takedatsu H; Okabe Y; Ishida Y; Sugiyama G; Yonemoto K; Mitsuyama K; Tsuruta O; Sata M
J Gastroenterol Hepatol; 2012 Feb; 27(2):268-72. PubMed ID: 21929654
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta-analysis.
Morselli-Labate AM; Pezzilli R
J Gastroenterol Hepatol; 2009 Jan; 24(1):15-36. PubMed ID: 19067780
[TBL] [Abstract][Full Text] [Related]
24. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
[TBL] [Abstract][Full Text] [Related]
25. Serum level of Ca 19-9 increases ability of IgG4 test to distinguish patients with autoimmune pancreatitis from those with pancreatic carcinoma.
van Heerde MJ; Buijs J; Hansen BE; de Waart M; van Eijck CH; Kazemier G; Pek CJ; Poley JW; Bruno MJ; Kuipers EJ; van Buuren HR
Dig Dis Sci; 2014 Jun; 59(6):1322-9. PubMed ID: 24385012
[TBL] [Abstract][Full Text] [Related]
26. Serum Immunoglobulin G4 in Discriminating Autoimmune Pancreatitis From Pancreatic Cancer: A Diagnostic Meta-analysis.
Dai C; Cao Q; Jiang M; Sun MJ
Pancreas; 2018 Mar; 47(3):280-284. PubMed ID: 29351121
[TBL] [Abstract][Full Text] [Related]
27. Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis.
Kamisawa T; Imai M; Egawa N; Tsuruta K; Okamoto A
Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1167-70. PubMed ID: 18936710
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel antibody associated with autoimmune pancreatitis.
Frulloni L; Lunardi C; Simone R; Dolcino M; Scattolini C; Falconi M; Benini L; Vantini I; Corrocher R; Puccetti A
N Engl J Med; 2009 Nov; 361(22):2135-42. PubMed ID: 19940298
[TBL] [Abstract][Full Text] [Related]
29. Clinical strategies for differentiating autoimmune pancreatitis from pancreatic malignancy to avoid unnecessary surgical resection.
Wu WC; Yao XZ; Jin DY; Wang DS; Lou WH; Qin XY
J Dig Dis; 2013 Sep; 14(9):500-8. PubMed ID: 23692995
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of B cell-activating factor in autoimmune pancreatitis.
Yamanishi H; Kumagi T; Yokota T; Azemoto N; Koizumi M; Kobayashi Y; Abe M; Murakami H; Hiasa Y; Matsuura B; Kawamoto H; Yamamoto K; Onji M
Pancreas; 2011 Aug; 40(6):840-5. PubMed ID: 21747319
[TBL] [Abstract][Full Text] [Related]
31. A new diagnostic endoscopic tool for autoimmune pancreatitis.
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A
Gastrointest Endosc; 2008 Aug; 68(2):358-61. PubMed ID: 18513718
[TBL] [Abstract][Full Text] [Related]
32. Serology in autoimmune pancreatitis.
Raina A; Greer JB; Whitcomb DC
Minerva Gastroenterol Dietol; 2008 Dec; 54(4):375-87. PubMed ID: 19047979
[TBL] [Abstract][Full Text] [Related]
33. The sensitivity of combined IgG4 and IgG in autoimmune pancreatitis.
Xin L; Liao Z; Hu LH; Li ZS
Am J Gastroenterol; 2010 Aug; 105(8):1902. PubMed ID: 20686470
[No Abstract] [Full Text] [Related]
34. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis.
Aparisi L; Farre A; Gomez-Cambronero L; Martinez J; De Las Heras G; Corts J; Navarro S; Mora J; Lopez-Hoyos M; Sabater L; Ferrandez A; Bautista D; Perez-Mateo M; Mery S; Sastre J
Gut; 2005 May; 54(5):703-9. PubMed ID: 15831920
[TBL] [Abstract][Full Text] [Related]
35. Serum IgG4 elevation in pancreatic cancer: diagnostic and prognostic significance and association with autoimmune pancreatitis.
Ngwa T; Law R; Hart P; Smyrk TC; Chari ST
Pancreas; 2015 May; 44(4):557-60. PubMed ID: 25785724
[TBL] [Abstract][Full Text] [Related]
36. Clinical differences between mass-forming autoimmune pancreatitis and pancreatic cancer.
Naitoh I; Nakazawa T; Hayashi K; Okumura F; Miyabe K; Shimizu S; Kondo H; Yoshida M; Yamashita H; Ohara H; Joh T
Scand J Gastroenterol; 2012 May; 47(5):607-13. PubMed ID: 22416894
[TBL] [Abstract][Full Text] [Related]
37. Circulating naïve and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis.
Miyoshi H; Uchida K; Taniguchi T; Yazumi S; Matsushita M; Takaoka M; Okazaki K
Pancreas; 2008 Mar; 36(2):133-40. PubMed ID: 18376303
[TBL] [Abstract][Full Text] [Related]
38. Infiltration of peritumoural but tumour-free parenchyma with IgG4-positive plasma cells in hilar cholangiocarcinoma and pancreatic adenocarcinoma.
Resheq YJ; Quaas A; von Renteln D; Schramm C; Lohse AW; Lüth S
Dig Liver Dis; 2013 Oct; 45(10):859-65. PubMed ID: 23602806
[TBL] [Abstract][Full Text] [Related]
39. Relationship between autoimmune pancreatitis and pancreatic cancer: a single-center experience.
Ikeura T; Miyoshi H; Uchida K; Fukui T; Shimatani M; Fukui Y; Sumimoto K; Matsushita M; Takaoka M; Okazaki K
Pancreatology; 2014; 14(5):373-9. PubMed ID: 25278307
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune pancreatitis: a systemic immune complex mediated disease.
Deshpande V; Chicano S; Finkelberg D; Selig MK; Mino-Kenudson M; Brugge WR; Colvin RB; Lauwers GY
Am J Surg Pathol; 2006 Dec; 30(12):1537-45. PubMed ID: 17122509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
